Home › Mild Cognitive Impairment › Minnesota › Rochester
Mild Cognitive Impairment clinical trials in Rochester, MN
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Mayo Clinic in Rochester, Minnesota, Rochester
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecruitingObservational study
- Mayo Clinic, Rochester
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Mayo Clinic, Rochester
Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
RecruitingObservational study
- Mayo Clinic, Rochester
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY24 studies
- Boston, MA23 studies
- Chicago, IL16 studies
- Baltimore, MD14 studies
- Los Angeles, CA12 studies
- Miami, FL12 studies
- San Francisco, CA11 studies
- Atlanta, GA10 studies
- Houston, TX10 studies
- Birmingham, AL10 studies
- Philadelphia, PA10 studies
- Durham, NC9 studies
Other studies in Rochester
- Breast Cancer39 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer27 studies
- Colorectal Cancer27 studies
- Multiple Myeloma25 studies
- Heart Failure21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Pancreatic Cancer20 studies
- Chronic Lymphocytic Leukemia20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.